175 related articles for article (PubMed ID: 30657785)
1. Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma.
Cozzi L; Comito T; Fogliata A; Franzese C; Franceschini D; Bonifacio C; Tozzi A; Di Brina L; Clerici E; Tomatis S; Reggiori G; Lobefalo F; Stravato A; Mancosu P; Zerbi A; Sollini M; Kirienko M; Chiti A; Scorsetti M
PLoS One; 2019; 14(1):e0210758. PubMed ID: 30657785
[TBL] [Abstract][Full Text] [Related]
2. Radiomic analysis to predict local response in locally advanced pancreatic cancer treated with stereotactic body radiation therapy.
Gregucci F; Fiorentino A; Mazzola R; Ricchetti F; Bonaparte I; Surgo A; Figlia V; Carbonara R; Caliandro M; Ciliberti MP; Ruggieri R; Alongi F
Radiol Med; 2022 Jan; 127(1):100-107. PubMed ID: 34724139
[TBL] [Abstract][Full Text] [Related]
3. Quantitative Analysis of (18)F-Fluorodeoxyglucose Positron Emission Tomography Identifies Novel Prognostic Imaging Biomarkers in Locally Advanced Pancreatic Cancer Patients Treated With Stereotactic Body Radiation Therapy.
Cui Y; Song J; Pollom E; Alagappan M; Shirato H; Chang DT; Koong AC; Li R
Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):102-9. PubMed ID: 27511850
[TBL] [Abstract][Full Text] [Related]
4. Predicting survival and local control after radiochemotherapy in locally advanced head and neck cancer by means of computed tomography based radiomics.
Cozzi L; Franzese C; Fogliata A; Franceschini D; Navarria P; Tomatis S; Scorsetti M
Strahlenther Onkol; 2019 Sep; 195(9):805-818. PubMed ID: 31222468
[TBL] [Abstract][Full Text] [Related]
5. Radiomics based analysis to predict local control and survival in hepatocellular carcinoma patients treated with volumetric modulated arc therapy.
Cozzi L; Dinapoli N; Fogliata A; Hsu WC; Reggiori G; Lobefalo F; Kirienko M; Sollini M; Franceschini D; Comito T; Franzese C; Scorsetti M; Wang PM
BMC Cancer; 2017 Dec; 17(1):829. PubMed ID: 29207975
[TBL] [Abstract][Full Text] [Related]
6. A radiomic approach to predicting nodal relapse and disease-specific survival in patients treated with stereotactic body radiation therapy for early-stage non-small cell lung cancer.
Franceschini D; Cozzi L; De Rose F; Navarria P; Fogliata A; Franzese C; Pezzulla D; Tomatis S; Reggiori G; Scorsetti M
Strahlenther Onkol; 2020 Oct; 196(10):922-931. PubMed ID: 31722061
[TBL] [Abstract][Full Text] [Related]
7. Computed Tomography Radiomics Predicts HPV Status and Local Tumor Control After Definitive Radiochemotherapy in Head and Neck Squamous Cell Carcinoma.
Bogowicz M; Riesterer O; Ikenberg K; Stieb S; Moch H; Studer G; Guckenberger M; Tanadini-Lang S
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):921-928. PubMed ID: 28807534
[TBL] [Abstract][Full Text] [Related]
8. CT imaging features associated with recurrence in non-small cell lung cancer patients after stereotactic body radiotherapy.
Li Q; Kim J; Balagurunathan Y; Qi J; Liu Y; Latifi K; Moros EG; Schabath MB; Ye Z; Gillies RJ; Dilling TJ
Radiat Oncol; 2017 Sep; 12(1):158. PubMed ID: 28946909
[TBL] [Abstract][Full Text] [Related]
9. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
[TBL] [Abstract][Full Text] [Related]
10. Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radiation.
Zhong J; Patel K; Switchenko J; Cassidy RJ; Hall WA; Gillespie T; Patel PR; Kooby D; Landry J
Cancer; 2017 Sep; 123(18):3486-3493. PubMed ID: 28493288
[TBL] [Abstract][Full Text] [Related]
11. CT-based radiomic analysis of stereotactic body radiation therapy patients with lung cancer.
Huynh E; Coroller TP; Narayan V; Agrawal V; Hou Y; Romano J; Franco I; Mak RH; Aerts HJ
Radiother Oncol; 2016 Aug; 120(2):258-66. PubMed ID: 27296412
[TBL] [Abstract][Full Text] [Related]
12. Radiomic analysis of planning computed tomograms for predicting radiation-induced lung injury and outcome in lung cancer patients treated with robotic stereotactic body radiation therapy.
Bousabarah K; Temming S; Hoevels M; Borggrefe J; Baus WW; Ruess D; Visser-Vandewalle V; Ruge M; Kocher M; Treuer H
Strahlenther Onkol; 2019 Sep; 195(9):830-842. PubMed ID: 30874846
[TBL] [Abstract][Full Text] [Related]
13. Assessing local progression after stereotactic body radiation therapy for unresectable pancreatic adenocarcinoma: CT versus PET.
Toesca DAS; Pollom EL; Poullos PD; Flynt L; Cui Y; Quon A; von Eyben R; Koong AC; Chang DT
Pract Radiat Oncol; 2017; 7(2):120-125. PubMed ID: 28274396
[TBL] [Abstract][Full Text] [Related]
14. Radiomic signature of
Jiang Y; Yuan Q; Lv W; Xi S; Huang W; Sun Z; Chen H; Zhao L; Liu W; Hu Y; Lu L; Ma J; Li T; Yu J; Wang Q; Li G
Theranostics; 2018; 8(21):5915-5928. PubMed ID: 30613271
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of 0.35 T magnetic resonance imaging radiomic features in stereotactic ablative body radiotherapy of pancreatic cancer: A pilot study.
Simpson G; Spieler B; Dogan N; Portelance L; Mellon EA; Kwon D; Ford JC; Yang F
Med Phys; 2020 Aug; 47(8):3682-3690. PubMed ID: 32329904
[TBL] [Abstract][Full Text] [Related]
16. Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery: A retrospective study.
Comito T; Cozzi L; Zerbi A; Franzese C; Clerici E; Tozzi A; Iftode C; Navarria P; D'Agostino G; Fogliata A; Mancosu P; Tomatis S; Carnaghi C; Personeni N; Santoro A; Scorsetti M
Eur J Surg Oncol; 2017 Apr; 43(4):735-742. PubMed ID: 28131670
[TBL] [Abstract][Full Text] [Related]
17. CT-based radiomic features predict tumor grading and have prognostic value in patients with soft tissue sarcomas treated with neoadjuvant radiation therapy.
Peeken JC; Bernhofer M; Spraker MB; Pfeiffer D; Devecka M; Thamer A; Shouman MA; Ott A; Nüsslin F; Mayr NA; Rost B; Nyflot MJ; Combs SE
Radiother Oncol; 2019 Jun; 135():187-196. PubMed ID: 30961895
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic body radiation therapy for locally advanced pancreatic cancer.
Jung J; Yoon SM; Park JH; Seo DW; Lee SS; Kim MH; Lee SK; Park DH; Song TJ; Ryoo BY; Chang HM; Kim KP; Yoo C; Jeong JH; Kim SC; Hwang DW; Lee JH; Song KB; Jo YY; Park J; Kim JH
PLoS One; 2019; 14(4):e0214970. PubMed ID: 30978229
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic body radiotherapy (SBRT) in recurrent or oligometastatic pancreatic cancer : A toxicity review of simultaneous integrated protection (SIP) versus conventional SBRT.
Gkika E; Adebahr S; Kirste S; Schimek-Jasch T; Wiehle R; Claus R; Wittel U; Nestle U; Baltas D; Grosu AL; Brunner TB
Strahlenther Onkol; 2017 Jun; 193(6):433-443. PubMed ID: 28138949
[TBL] [Abstract][Full Text] [Related]
20. Radiomics-based Assessment of Radiation-induced Lung Injury After Stereotactic Body Radiotherapy.
Moran A; Daly ME; Yip SSF; Yamamoto T
Clin Lung Cancer; 2017 Nov; 18(6):e425-e431. PubMed ID: 28623121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
